Zobrazeno 1 - 10
of 92
pro vyhledávání: '"Jeffrey, Bratberg"'
Autor:
Anthony S. Floyd, Joseph Silcox, Gail Strickler, Thuong Nong, Malcolm Blough, Derek Bolivar, Megan Rabin, Jeffrey Bratberg, Adriane N. Irwin, Daniel M. Hartung, Ryan N. Hansen, Robert Bohler, Traci C. Green
Publikováno v:
Drug and Alcohol Dependence Reports, Vol 11, Iss , Pp 100243- (2024)
Background: As the US opioid-involved morbidity and mortality increase, uptake and implementation of evidence-based interventions remain key policy responses. Respond to Prevent was a multi-component, randomized trial implemented in four states and t
Externí odkaz:
https://doaj.org/article/3f57f47cef1c46df9741c81d50cc58c8
Autor:
Michael A Irvine, PhD, Declan Oller, PhD, Jesse Boggis, MPH, Brian Bishop, PharmD, Daniel Coombs, ProfPhD, Eliza Wheeler, MPA, Maya Doe-Simkins, MPH, Alexander Y Walley, ProfMD, Brandon D L Marshall, PhD, Jeffrey Bratberg, PharmD, Traci C Green, ProfPhD
Publikováno v:
The Lancet Public Health, Vol 7, Iss 3, Pp e210-e218 (2022)
Summary: Background: The US overdose crisis is driven by fentanyl, heroin, and prescription opioids. One evidence-based policy response has been to broaden naloxone distribution, but how much naloxone a community would need to reduce the incidence of
Externí odkaz:
https://doaj.org/article/bbb8a37fd7eb402d96b2deef273c6cff
Publikováno v:
Substance Use & Misuse. 58:1038-1045
Autor:
Mary Gray, Sarah S. Shin, Joseph Silcox, Diana Flores, Derek Bolivar, Adriane N. Irwin, Anthony S. Floyd, Jeffrey Bratberg, Jesse S. Boggis, Daniel M. Hartung, Traci C. Green
Publikováno v:
Journal of the American Pharmacists Association. 63:838-846
Autor:
Eric P. Borrelli, PhD, PharmD, MBA, Jeffrey Bratberg, PharmD, FAPhA, Mary L. Greaney, PhD, MPH, Stephen J. Kogut, PhD, MBA, RPh
Publikováno v:
Journal of Opioid Management. 19:257-271
Objective: To assess prescribing of tramadol among patients with contraindications and higher risks of adverse events in a large population of commercially insured and Medicare Advantage members. Design: We performed a cross-sectional analysis evalua
Publikováno v:
Pharmacoepidemiology
Volume 1
Issue 3
Pages: 101-112
Volume 1
Issue 3
Pages: 101-112
Opioid use disorder (OUD) is a chronic disease requiring long-term treatment and is associated with opioid overdose and increased risk of mortality. However, existing randomized clinical trials focused on short-term treatment engagement and detoxific
Autor:
Deborah S. Finnell, Victoria Soltis-Jarrett, Jeffrey Bratberg, Andrew Muzyk, Yifei Liu, Ellen Edens, J. Paul Seale, Jill Mattingly, Kristen Schnurman, Victoria Osborne-Leute, Allen Zweben, Ann Cary, Brent A. Moore
Publikováno v:
Substance Abuse. 43:1363-1369
Autor:
Raagini Jawa, Alexander Y. Walley, Donna J. Wilson, Traci C. Green, Michelle McKenzie, Randall Hoskinson, Jeffrey Bratberg, Susan Ramsey, Josiah D. Rich, Peter D. Friedmann
Publikováno v:
JAIDS Journal of Acquired Immune Deficiency Syndromes. 90:546-552
Autor:
Haley Pals, Jeffrey Bratberg
Publikováno v:
Journal of the American Pharmacists Association. 62:1422-1429
As the death toll continues to rise in the opioid overdose epidemic, increasing access to medications for opioid use disorder (OUD), such as buprenorphine, is vital. Psychiatric clinical pharmacist practitioners (CPPs) can help bridge the gap in care
Publikováno v:
Am J Public Health